Plus   Neg

Integra Lifesciences Holdings (IART) Is Falling After Q3 Report

Integra Lifesciences Holdings (IART) reported third quarter adjusted EPS of $0.59 Wednesday morning, which was in line with analysts' expectations.

The company continues to expect to report full year adjusted EPS of $2.36 to $2.42. However, the company lowered its full-year revenue guidance to a range of $1.467 billion to $1.472 billion, from the prior forecast range of between $1.475 billion and $1.490 billion.

Integra Lifesciences Holdings gapped open sharply lower this morning and is now down 8.64 at $53.68. The stock has dropped to nearly a 7-month low.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT